Abstract
Severity differences may in part explain the large varia tions in asthma mortality that occur in different coun tries. This study examines the use of APACHE II for measuring asthma severity in 118 adult asthma admis sions at one intensive care unit in New Zealand during 1987-1988. Most admissions were hypercapnic (72%), and 61 % had an altered level of consciousness. Mean APACHE II score was 20 in the emergency department and 12 upon ICU admission. We summarize the extent of physiological derangement using four acute physiol ogy score (APS) ranges. Each APS range stratified admis sions into groups with differing clinical course, therapy, and outcome. These results document a high level of asthma severity among patients treated in New Zealand, the country with the world's highest asthma mortality. APACHE II provides a valid and reproducible measure of asthma severity and should be useful for describing and comparing international differences in asthma severity and as a case-mix control in studies of asthma therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
